Arrivent BioPharma, Inc. (AVBP)
22.95
-0.14
(-0.61%)
USD |
NASDAQ |
Feb 20, 16:00
22.95
0.00 (0.00%)
After-Hours: 17:10
Arrivent BioPharma Total Liabilities (Quarterly) : 21.56M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.665B |
| AIM ImmunoTech, Inc. | 11.57M |
| Bristol Myers Squibb Co. | 71.53B |
| Annexon, Inc. | 67.70M |
| Spruce Biosciences, Inc. | 9.927M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 326.56M |
| Shareholders Equity (Quarterly) | 305.00M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 14.90 |
| Net Debt Paydown Yield | 0.01% |